Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: How physicians manage treatment failures

Journal of Rheumatology

Volumn 25, Issue 11, 1998, Pages 2088-2093

  Spencer Green, George ^a,b   Spencer Green, Elizabeth ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Efficacy; Nonsteroidal antiinflammatory drugs; Osteoarthritis; Physician's practice patterns; Rheumatoid arthritis; Toxicity

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; MISOPROSTOL; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPRAZINE; PROTON PUMP INHIBITOR;

ARTICLE; DRUG EFFICACY; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HUMAN; MEDICAL PRACTICE; MEDICAL SPECIALIST; OSTEOARTHRITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DYSPEPSIA; FAMILY PRACTICE; HUMANS; OSTEOARTHRITIS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RETREATMENT; TREATMENT FAILURE;

EID: 0031731944     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Brooks PM, Day RO. Drug therapy: nonsteroidal antiinflammatory drugs - differences and similarities. N Engl J Med 1991;324:1716-25.
3. Spencer-Green G. Drug treatment of arthritis. Update on conventional and less conventional methods. Postgrad Med 1993;93:129-40.
4. Macfarlane D. Osteoarthritis. Practitioner 1992;236:1061-5.
5. Liang MHF. Management of osteoarthritis of the hip and knee. N Engl J Med 1991;325:125-7.
6. Soil AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal antiinflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-19.
7. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54.
8. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
9. Dieppe P, Cushnaghan J, Jasani MK, McCrae F, Watt I. A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol 1993;32:595-600.
10. Scholes D, Stergachis A, Penna PM, Normand EH, Hansten PD. Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis. J Rheumatol 1995;22:708-12.
11. Ekstrom P, Carling L, Wetterhus S. et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scan J Gastro 1996;31:753-8.
12. Hawkey CJ. Gastroduodenal problems associated with non-steroidal, anti-inflammatory drugs. Scan J Gastroenterol Suppl 1993;200:94-5.
13. Larkai EN, Smith JL, Lidsky MD, Sessoms SL, Graham DY. Dyspepsia in NSAID users: the size of the problem. J Clin Gastroenterol 1989;11:158-62.
14. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheum 1993;36:84-90.
15. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
16. Holt RJ, Fort J. The development of clinical practice guidelines for treatment of peptic acid diseases in a VA ambulatory care clinic - a comment. Pharmacotherapy 1996;16:480-1.
17. Wasson JH, Kairys SW, Nelson EC, Kalishman N, Baribeau P. A short survey for assessing health and social problems of adolescents. Dartmouth Primary Care Cooperative Information Project (The COOP). J Fam Prac 1994;38:489-94.
18. StataCorp, College Station, TX.: Stata Statistical Software: Release 4.0, 1995.
19. 4th Dimension, Cupertino, CA: ACI US, Inc., 1994.
20. Pagano M, Gauvreau K. Principles of biostatistics. Belmont: Wadsworth Publishing; 1993:305-8.
21. Nived O, Sturfelt G, Eckernas SA, Singer P. A comparison of 6 months' compliance of patients with rheumatoid arthritis treated with tenoxicam and naproxen. Use of patient computer data to assess response to treatment. J Rheumatol 1994;21:1537-41.
22. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturersupported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994;154:157-63.
23. Huskisson EC. Four commonly prescribed non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Eur J Rheumatol Inflamm 1991;11:8-12.
24. Van Groenendael JH, Markusse HM, Dijkmans BA, Breedveld FC. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1996;15:450-6.
25. Doherty M, Hunt RH, Langman MJ, Pounder RE, Russell RI, Sturrock RD. Management of NSAID induced gastrointestinal disturbance. Ann Rheum Dis 1987;46:640-3.
26. Roth SH, Bennett RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation. Arch Intern Med 1987;147:1798-801.
27. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993;36:1196-206.
28. van der Heide A, Jacobs WG, Bijlsma JWJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs. Ann Intern Med 1996;124:699-707.
29. Weinblatt ME. Rheumatoid arthritis: treat now, not later. Ann Intern Med 1996;124:773-4.
30. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995;123:241-9.
31. Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 1993;119:257-62.
32. Spector TD, Dacre JE, Harris PA, Huskisson EC. Radiological progression of osteoarthritis: an 11 year follow up study of the knee. Ann Rheum Dis 1992;51:1107-10.
33. Lane NE, Michel B, Bjorkengren A, et al. The risk of osteoarthritis with running and aging: a 5-year longitudinal study. J Rheumatol 1993;20:461-8.
34. Wijnands MJ, van't Hof MA, van Leeuwen MA, van Rijswijk MH, van de Putte LB, van Riel PL. Long-term second-line treatment: a prospective drug survival study. Br J Rheumatol 1992;31:253-8.
35. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol 1992;19:1885-94.
36. Meenan RF, Kazis LE, Anderson JJ. The stability of health status in rheumatoid arthritis: a five-year study of patients with established disease. Am J Public Health 1988;78:1484-7.